Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOncoCyte Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2027 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2027 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2027 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2027 | 1 | -$0.20 | -$0.20 | -$0.20 |
OncoCyte Corporation Earnings Date And Information
OncoCyte Corporation last posted its earnings results on Wednesday, August 6th, 2025. The company reported $-0.30422 earnings per share for the quarter, missing analysts' consensus estimates of $-0.24 by $0.06422. The company had revenue of 260.00 K for the quarter and had revenue of 1.88 M for the year. OncoCyte Corporation has generated $-5 earnings per share over the last year ($-4.66 diluted earnings per share) and currently has a price-to-earnings ratio of -0.03. OncoCyte Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based on prior year's report dates.
OncoCyte Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | N/A | -$0.34 | N/A | $283.90 K | $260.00 K |
| 08/11/2025 | Q2 2025 | N/A | -$0.30 | N/A | $291.95 K | $518.00 K |
| 05/12/2025 | Q1 2025 | -$0.24 | -$25.96 | -25.72 | N/A | $2.14 M |
| 03/24/2025 | Q4 2024 | -$0.43 | -$1.93 | -1.5 | N/A | $1.49 M |
| 11/12/2024 | Q3 2024 | -$0.44 | -$0.98 | -0.54 | $178.33 K | $115.00 K |
| 08/08/2024 | Q2 2024 | -$0.56 | -$0.36 | 0.2 | $318.55 K | $104.00 K |
| 05/15/2024 | Q1 2024 | -$0.67 | -$1.10 | -0.43 | N/A | $176.00 K |
| 04/15/2024 | Q4 2023 | N/A | -$1.94 | N/A | N/A | $314.00 K |
| 11/09/2023 | Q3 2023 | -$1.52 | -$0.79 | 0.73 | $312.50 K | $429.00 K |
| 08/10/2023 | Q2 2023 | -$2.60 | -$1.17 | 1.43 | $362.50 K | $463.00 K |
| 05/12/2023 | Q1 2023 | N/A | $0.40 | N/A | $346.40 K | $297.00 K |
| 04/12/2023 | Q4 2022 | N/A | -$7.64 | N/A | $1.48 M | $-3,550,000 |
| 11/10/2022 | Q3 2022 | -$2.60 | -$1.59 | 1.01 | $2.71 M | $1.02 M |
| 08/11/2022 | Q2 2022 | N/A | -$1.42 | N/A | $2.24 M | $2.07 M |
| 05/12/2022 | Q1 2022 | N/A | -$2.32 | N/A | $3.52 M | $1.42 M |
| 05/02/2022 | Q4 2021 | N/A | -$7.88 | N/A | $1.75 M | $3.59 M |
| 11/09/2021 | Q3 2021 | -$1.40 | -$3.02 | -1.62 | $1.57 M | $984.00 K |
| 08/11/2021 | Q2 2021 | N/A | -$2.34 | N/A | $838.02 K | $2.03 M |
| 05/17/2021 | Q1 2021 | -$1.80 | -$0.95 | 0.85 | $807.90 K | $1.12 M |
| 03/19/2021 | Q4 2020 | N/A | -$1.87 | N/A | $366.67 K | $503.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
OncoCyte Corporation Earnings: FAQ's
OncoCyte Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based offlast year's report dates.
The conference call for OncoCyte Corporation's latest earnings report can be listened to online.
The conference call transcript for OncoCyte Corporation's latest earnings report can be read online.
OncoCyte Corporation (:OCX) has a recorded annual revenue of $1.88 M.
OncoCyte Corporation (:OCX) has a recorded net income of $-60,663,000.OncoCyte Corporation has generated $-4.66 earnings per share over the last four quarters.
OncoCyte Corporation (:OCX) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is -0.13.